Profile of Speaker/Author
Mr. Lewis has served as CFO for a number of biotechnology
companies including, Bio-Tech Imaging, Inc., and Panacea
Biotech Ltd. He is also a founder of Iomai Corporation and
served as the company.s first President and CEO. Mr. Lewis
has over 20 years of direct experience in investment banking
and corporate finance in the U.S., Europe, Asia, Latin
America and Africa over a wide variety of industries, as
well as service to the New Zealand Treasury and with the
World Bank subsidiary, International Finance Corporation.
Pacific Rim Capital, LLC, is an Annapolis-based consulting
firm offering financial management for biotech start-ups,
emphasizing capital structuring and fund raising.
Abstract of Presentation/Publication
A US biotech company is usually funded from US government
and US private equity sources. Less known are the means of
financing from overseas investors. In his presentation, Mr.
Lewis will discuss in detail three aspects of international
financing available to local biotechs: Pure equity,
Strategic Alliances, and Combination Financing. He will
detail specific sources and conditions of financing typical
of investors in Japan, Korea, Taiwan, Hong Kong, and
Singapore. Names of potential investors will be given and
suggestions on making contact with them will be offered. US
biotech executives should consider financing from overseas
investors as a component of their overall funding
strategy.
